Action Research to Resolve the Problems of Illegal Advertising of Health Products in Pharmacies in Chonburi Province
Main Article Content
Abstract
Objective: To address the issue of illicit advertising of health products (AHP) within community pharmacies in Chonburi. Methods: This action research employed the PDCA quality cycle framework in 120 owners of modern pharmacies. The Plan phase (P) involved focus group discussion among 18 key informants whose work related to AHP in pharmacies, and having more than 10 years of experience in this field. The informants analyzed and prioritized the problems, designed the program to resolve the problems, and planed for program implementation. The Do phase (D) was the implementation of program designed in the Plan phase. A questionnaire was used to measure pharmacy owners’ knowledge on laws related to AHP, attitudes about legal AHP, and awareness of the impact of illicit AHP before and after participating in the program activities. The researchers visited the pharmacies to inspect legal compliance of AHP 2 weeks after the activities. In the Check phase (C), a focus group discussion of 18 key informants in the planning phase was held to evaluate the program according to the specified goals, reflect on the problems and suggest how to resolve them in the next cycle of effort. In Act stage (A) was the revision of strategies to avoid problems encountered during the PDC stage in order to strengthen the program and expanding it to other areas. Results: Three factors leading to legal violation of AHP were 1) lack of related knowledge or ignorance of pharmacy owners and/or pharmacy practitioners; 2) poor attitudes towards legal compliance on AHP; and 3) lack of awareness of the impact of AHP. The program for addressing illicit AHP in pharmacies involved 4 activities including 1) knowledge building activities, 2) attitude change activities, and 3) activities for raising awareness of the impact of AHP; and 4) correction of AHP in pharmacy. After participating in the activities, there was a statistically significant increase in the scores on knowledge on the law relating to AHP, attitudes toward legal AHP and awareness of impact of AHP, compared to those measured before participating in the activities (P<0.05). Assessment of all pharmacies did not find any illegal acts related to AHP Conclusion: Addressing the offenses associated with AHP in pharmacies through action research was effective, leading pharmacy owners to legally advertise health products.
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
Food and Drug Administration, Ministry of Public Health. Guide to advertising health products. Bangkok: Agricultural Cooperative; 2012.
Academic Center for Surveillance and Drug System Development, Faculty of Pharmaceutical Sciences, Chulalongkorn University. Guidelines for handling advertising problems on online media and other media [online]. 2019. [cited May 27, 2022]. Available from: www.thaidrugwatch.org/download/series/serie s40.pdf.
Ampant P. Situations, problems, and model develop- ment to solve the problems associated with the radio broadcasting advertisement of health products in Sisaket Province. Journal of Health Science 2015; 24: 1060-9.
Nitikarun S, Upakdee N. The distribution of community pharmacies in the context of health need in Thailand. Journal of Health Systems Research 2020; 14: 71-87.
Thavornwattanayong W. Opportunities and develop- ments for the pharmacy business after the 2019 novel coronavirus outbreak. Thai Bulletin of Pharma- ceutical Sciences 2020; 15: 95-107
Vittayarat K. Process of health product advertising among the operators of local radios: A qualitative approach [master thesis]. Songkhla: Prince of Songkla University; 2014.
Chonburi Public Health Office. Statistics on phar- macy registration (January–December). Chonburi: Chonburi Public Health Office; 2021.
Chonburi Public Health Office. Report on concerns on health product marketing (January– December). Chonburi: Chonburi Public Health Office; 2021.
Sombutpoothon P, Reamrimmadun Y, Thamniab W, Thanmaneesin K. Violations of laws on advertise- ment of health products by pharmacies in Chonburi with a history of such offenses. Thai Journal of Pharmacy Practice 2024; 16: 657-68
Notification of the Ministry of Public Health on determination of places equipment and practices of community pharmaceuticals in the place where community pharmacy are conducted according to the Drug Act B.E. 2557. Royal Gazette No. 131, Part 223D special (Nov 5, 2014).
Mycot ed. Plan Do Check Act (PDCA) [online]. 2004. [cited May 27, 2022]. Available from: www.mycoted. com/creativity/techniques/pdca.php.
Pattamasaravut P, Muenpa R. Development of model grocery store from the civil state project on collective action for drugs safety in communities. Thai Journal of Pharmacy Practice 2020; 12: 601-11.
Schwartz NE. nutritional knowledge, attitude and practices of high school graduates. J Am Diet Assoc 1975; 66: 28–31.
Onprasert P. A Development approach for phar- macy to reach standards of quality pharmacy in Yala Province [master thesis]. Songkhla: Prince of Songkla University; 2015.
Sombutpoothon P. Factors on drug store with good pharmacy practice to abide the criterion of the quality pharmacy at Chonburi Province [master thesis]. Pitsanulok: Naresuan University; 2021.
Meeduang A, Arpasrithongsakul S. Development of a model for Reducing the use of Ya-chud in community by the Council of Community Organiza- tion in Tumbon Ban-Ku, Yangsisurat District, Maha sarakham. Thai Journal of Pharmacy Practice 2022; 14: 70-85.
Thongyoung P, Komwuthikarn K. Development of drugstores to Good Pharmacy Practice by participa- tory action research in Samutsongkhram Province. Thai Food and Drug Journal 2018; 25: 39-48.